White matter hyperintensities (WMHs) are bright spots that appear on brain MRI scans, signaling areas where the white matter tissue has been damaged or is holding excess fluid. They are extremely common in older adults, showing up in about 15% of people at age 60 and climbing to roughly 80% by age 80. Small, scattered spots are often considered a normal part of aging, but larger or more extensive patches are linked to meaningful health risks, including double the risk of dementia and triple the risk of stroke.
How They Appear on MRI
White matter hyperintensities get their name from how they look on specific types of MRI sequences called T2 and FLAIR imaging. On these scans, areas with excess water in the tissue glow bright white against the darker surrounding brain, making them easy to spot. The brightness reflects increased water content in the spaces between cells, which can result from tissue damage, inflammation, or fluid buildup.
Radiologists typically describe WMHs by their location. Periventricular WMHs sit right next to the fluid-filled ventricles in the center of the brain and can appear as thin lines, small caps at the corners of the ventricles, or smooth halos around them. Deep WMHs are found further out in the brain’s white matter and tend to start as small punctate dots, then gradually merge into larger patches as they progress.
What Causes Them
The white matter deep in the brain is supplied by long, thin arteries that branch off from larger vessels. Because these small arteries are at the tail end of the blood supply chain, the tissue they feed is particularly vulnerable when blood flow drops. Chronic reduced blood flow, known as hypoperfusion, is one of the primary drivers of WMHs. Over time, inadequate blood delivery damages the insulating coating (myelin) around nerve fibers, disrupts the tissue, and allows fluid to accumulate.
Another mechanism involves the blood-brain barrier, a protective lining that normally keeps blood proteins out of brain tissue. When this barrier becomes leaky, proteins like fibrinogen seep into the surrounding white matter. This triggers inflammation, activates immune cells in the brain, damages nerve fibers, and breaks down myelin. A newer theory also points to problems with the brain’s waste-clearance system (the glymphatic system), which normally flushes fluid through the brain during sleep. When this system fails, fluid can pool in the white matter, potentially contributing to tissue damage and WMH formation.
Risk Factors That Speed Progression
High blood pressure is the strongest and most consistent risk factor. Research shows that hypertension accelerates the loss of white matter integrity, particularly in middle-aged adults, suggesting the damage can begin well before WMHs become visible on a scan. The relationship is dose-dependent: the higher and longer-lasting the blood pressure elevation, the more WMHs tend to accumulate.
Diabetes is another major contributor. People with diabetes consistently show greater deterioration in white matter structure, even after accounting for blood pressure and body weight. Obesity and smoking round out the most well-established modifiable risk factors, each independently associated with measurable declines in white matter health. Age itself remains the single biggest non-modifiable factor, with WMH burden increasing steadily decade by decade.
Effects on Thinking, Movement, and Bladder Control
The cognitive effects of WMHs tend to show up first in processing speed and executive function, the mental skills you use for planning, organizing, and switching between tasks. As WMH volume grows, the risk of progressing to dementia roughly doubles compared to people with minimal or no WMHs.
What many people don’t expect is the physical impact. WMHs are strongly linked to problems with walking and balance. They also predict worsening bladder control. In one study, for every 1% increase in total WMH volume relative to brain size, the odds of moderate to severe urinary incontinence, slow walking speed, and poor balance scores increased 1.5 to 2.4 times. These physical symptoms can be just as disabling as the cognitive ones, and WMH volume predicted mobility and bladder decline with greater consistency than it predicted cognitive decline in the same group of subjects.
How Doctors Grade Severity
The most widely used rating system is the Fazekas scale, which assigns a score from 0 to 3 based on how the WMHs look on MRI:
- Grade 0: No white matter hyperintensities visible.
- Grade 1: Small, punctate (dot-like) spots scattered in the white matter. This is considered low burden and is common in healthy older adults.
- Grade 2: The dots have started merging into larger patches, described as “early confluent.” This marks the transition to high burden.
- Grade 3: Large confluent areas where the spots have merged into extensive regions of abnormal signal. This grade carries the highest risk for cognitive decline, stroke, and functional problems.
People with the most WMHs at baseline also tend to accumulate new ones fastest. In one study following patients after a minor stroke, those who started with higher WMH volumes showed the greatest growth over the following year, and that growth was associated with more recurrent strokes and other cerebrovascular events.
WMHs vs. Multiple Sclerosis Lesions
Because both age-related WMHs and multiple sclerosis (MS) produce bright spots on MRI, distinguishing them matters. The patterns are different in several key ways. Age-related WMHs tend to be symmetrical on both sides of the brain and sit near (but not directly touching) the ventricles. MS lesions are typically asymmetrical and often press right up against the ventricular walls.
Location is the biggest clue. MS frequently involves the corpus callosum (the band connecting the two brain hemispheres), the temporal poles, the optic nerves, and the outer edges of the brainstem. Age-related WMHs rarely appear in any of these areas. MS also affects the U-shaped fibers just beneath the cortex and the cortex itself, while vascular WMHs generally do not. If your MRI report mentions lesions in these locations, your doctor will likely investigate MS or other inflammatory conditions rather than attributing the findings to normal aging or vascular disease.
Slowing Progression
Blood pressure control is the most evidence-backed strategy. A large clinical trial published in JAMA found that targeting a systolic blood pressure below 120 mm Hg, compared to the standard target of below 140 mm Hg, resulted in significantly less growth of white matter lesion volume over time. Lowering blood pressure also correlated with WMH reduction in stroke patients: those whose WMHs actually shrank over one year had larger drops in blood pressure, while those whose WMHs grew experienced nearly twice the rate of recurrent strokes (32% vs. 16%).
Managing diabetes, maintaining a healthy weight, staying physically active, and not smoking all protect white matter integrity based on the available evidence. Because the small blood vessels feeding the white matter are so sensitive to metabolic and vascular stress, these everyday health behaviors have an outsized effect on what happens deep inside the brain over decades.